Home›Search›MedComm - Future Medicine

MedComm - Future Medicine

John Wiley and Sons Inc · China · Est. 2022

ISSN2769-6456

SJR Q2✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Scopus Q266

✓ Corroboration (2 more)+12

Total78

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

145

days submission → published

measured · last 16 articles · accept 122d

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 50% in field

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Scorei

0.709

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

Total Worksi

168

Total Citationsi

614

2yr Mean Citednessi

1.64

Open Impact Factor alternative

Aims & Scope

Subject areas: Medicine (miscellaneous).

General Information

Country / RegionChina

Primary LanguageEnglish

1st Year Published2022

FrequencyQuarterly

StatusActive (last: 2026)

Total Publications168

Publisher OrgWiley

OA Since2021

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~15 weeks

Acceptance Rate—

OA LicenseCC BY

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

John Wiley and Sons Inc

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2769-6456

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

117

2022

364

2023

144

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q2

Subject Classification

Scopus Categories

Medicine (miscellaneous)

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersDiverse Scientific and Economic StudiesHuman auditory perception and evaluationEducational Robotics and EngineeringCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchArtificial Intelligence in Healthcare and EducationRadiomics and Machine Learning in Medical ImagingMachine Learning in HealthcareMicroRNA in disease regulation

Frequently asked questions about MedComm - Future Medicine

Is MedComm - Future Medicine a predatory journal?

PubScope has no integrity flags on record for MedComm - Future Medicine: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 78/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of MedComm - Future Medicine?

MedComm - Future Medicine is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.709.

Is MedComm - Future Medicine indexed in Scopus and Web of Science?

MedComm - Future Medicine is indexed in Scopus, DOAJ.

What is the aims and scope of MedComm - Future Medicine?